In one paragraphArticle in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Alice de Freitas GomesPost-Graduate Program in Hematology, The State University of Amazon (UEA), Foundation of Hematology and Hemotherapy of Amazonas, Manaus 69050-010, AM, Brazil.
Adriane Dâmares de Souza Jorge BatalhaLaboratory of Innovative Therapies, Federal University of Amazonas (UFAM)), Manaus 69077-000, AM, Brazil.
Carlos Eduardo de Castro AlvesLaboratory of Virology and Immunology, National Institute of Amazonian Research (INPA), Manaus 69067-375, AM, Brazil.
Renata Galvão de AzevedoLaboratory of Virology and Immunology, National Institute of Amazonian Research (INPA), Manaus 69067-375, AM, Brazil.
Jesus Rafael Rodriguez AmadoPost-Graduate Program in Health Sciences, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados 79825-070, MS, Brazil.ORCID 0000-0001-7574-6219 Tatiane Pereira de SouzaPost-Graduate Program in Pharmaceutical Innovation, Federal University of Amazonas (UFAM)), Manaus 69077-000, AM, Brazil.ORCID 0000-0003-1164-2191 Hector Henrique Ferreira KoolenResearch Group in Metabolomics and Mass Spectrometry, Amazonas State University (UEA), Manaus 690065-130, AM, Brazil.ORCID 0000-0002-0181-348X Felipe Moura Araújo da SilvaMultidisciplinary Support Center, Federal University of Amazonas (UFAM)), Manaus 69080-900, AM, Brazil.
Francisco Celio Maia ChavesEmbrapa Western Amazonia, Manaus 69010-970, AM, Brazil.
Serafim Florentino NetoPost-Graduate Program in Health Sciences, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados 79825-070, MS, Brazil.
Antônio Luiz BoechatPost-Graduate Program in Basic and Applied Immunology, Institute of Biological Science, Federal University of Amazonas (UFAM), Manaus 69077-000, AM, Brazil.ORCID 0000-0001-5597-7343 Gemilson Soares PontesPost-Graduate Program in Hematology, The State University of Amazon (UEA), Foundation of Hematology and Hemotherapy of Amazonas, Manaus 69050-010, AM, Brazil.ORCID 0000-0001-9001-7954 Funding
Foundation of the State of Amazonas (FAPEAM) CT&I ÁREAS PRIORITÁRIAS #01.02.016301.03422/2021-03; MAECI#01.02.016301.01582/2022-07he Coordination of Improvement of Higher Education Personnel (CAPES) PROCAD AMAZÔNIA 88881.200581/201801
6 · The paper itselfAbstract
Nanocapsules provide selective delivery and increase the bioavailability of bioactive compounds. In this study, we examined the anticancer and immunomodulatory potential of
Indexed as
cytotoxicityFridericia chicaimmunomodulationmyeloid leukemiasnanocapsules
Identifiers
PMID38931948
PMCPMC11207419
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390